Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-02-14
STMLStemline Therapeutics IncBergstein IvanCEOS - Sale$10.98-34,1322,749,056-1%-$374,769
2019-02-15
AMRNAmarin Corp PlcukKalb Michael WayneSVP, CFOS - Sale$17.58-25,00020,551-55%-$439,525
D
2019-02-15
AMPHAmphastar Pharmaceuticals, Inc.Peters William JCFO, SVP, TreasurerS - Sale+OE$24.37-10,01675,550-12%-$244,090
2019-02-13
VERUVeru Inc.Steiner Mitchell ShusterPres, CEO, 10%S - Sale$1.52-4,6507,929,6620%-$7,085
2019-02-15
VERUVeru Inc.Fisch HarryDir, 10%P - Purchase$1.36+13,6818,034,7210%+$18,654
D
2019-02-14
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$95.20-4,000469,631-1%-$380,800
D
2019-02-14
AMPHAmphastar Pharmaceuticals, Inc.Shandell Jason B.Pres, GCS - Sale+OE$23.99-7,519168,318-4%-$180,381
2019-02-13
GWPHGw Pharmaceuticals PlcGover Justin D.CEOS - Sale$12.50-22,620370,445-6%-$282,750
M
2019-02-13
AMARAmarillo Biosciences IncChen Stephen TPres,COB,CEO,CFO, 10%P - Purchase$0.25+151,0006,767,360+2%+$37,900
D
2019-02-14
ZTSZoetis Inc.Lewis Clinton A. Jr.EVPS - Sale+OE$91.96-6,12539,387-13%-$563,255
D
2019-02-13
RYTMRhythm Pharmaceuticals, Inc.Gottesdiener Keith MichaelCEO, PresS - Sale+OE$30.00-3,934540,986-1%-$118,020
2019-02-12
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.02+17,50021,362,1230%+$390
2019-02-12
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.02+213,00042,664,246+1%+$4,807
D
2019-02-14
VTVTVtv Therapeutics Inc.Perelman Ronald O10%P - Purchase$1.84+815,21715,678,436+5%+$1,499,999
2019-02-13
MYOKMyokardia IncSanofi10%S - Sale$37.66-4,168,8990-100%-$157,000,736
D
2019-02-12
ZGNXZogenix, Inc.Garner Cam LDirS - Sale+OE$46.85-12,40540,843-23%-$581,147
DM
2019-02-12
AMPHAmphastar Pharmaceuticals, Inc.Liawatidewi YakobSVP Corp Admin CenterS - Sale+OE$23.86-8,86842,252-17%-$211,632
D
2019-02-12
MRKMerck & Co., Inc.Chattopadhyay SanatExe V-P, Pres MMDS - Sale+OE$78.62-73,72751,467-59%-$5,796,306
D
2019-02-13
MRKMerck & Co., Inc.Weeks Wendell PDirS - Sale+OE$78.71-5,000100-98%-$393,548
D
2019-02-14
MRKMerck & Co., Inc.Karachun Rita ASVP Fince-Global ControllerS - Sale+OE$78.96-64,66216,175-80%-$5,105,951
D
2019-02-12
IONSIonis Pharmaceuticals IncO'Neil Patrick R.SVP Legal, GCS - Sale+OE$59.50-27519,673-1%-$16,363
D
2019-02-13
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$60.09-46,904800,557-6%-$2,818,268
2019-02-13
IONSIonis Pharmaceuticals IncGeary Richard SSVP, DevelopmentS - Sale$60.00-99921,442-4%-$59,940
2019-02-12
SAGESage Therapeutics, Inc.Starr Kevin PDirS - Sale$0.00-0302,8170%-$0
M
2019-02-12
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$12.36-13,1912,953,3820%-$163,013
2019-02-12
GBTGlobal Blood Therapeutics, Inc.Calhoun Lesley AnnSee RemarksS - Sale$50.45-3541,032-26%-$17,860
M
2019-02-12
SYBXSynlogic, Inc.Miller Paul FrancisChief Scientific OfficerS - Sale$9.75-9,00048,135-16%-$87,750
M
2018-12-21
XBITXbiotech Inc.Rennes Fondation10%P - Purchase$9.25+112,3003,698,282+3%+$1,039,049
D
2019-02-13
TEVATeva Pharmaceutical Industries LtdDe Notaristefani CarloEVP Global OperationsS - Sale+OE$17.88-5,04112,121-29%-$90,108
2019-02-13
ENTAEnanta Pharmaceuticals IncGardiner Nathaniel S.SVP, GCS - Sale$95.28-3,27023,978-12%-$311,562
DM
2019-02-11
ENTAEnanta Pharmaceuticals IncOr Yat SunSVP, CSOS - Sale+OE$89.52-33,981310,673-10%-$3,041,910
DM
2019-02-11
ENTAEnanta Pharmaceuticals IncGolumbeski GeorgeDirS - Sale+OE$90.06-13,5000-100%-$1,215,853
M
2019-02-11
RTRXRetrophin, Inc.Reed Elizabeth ESVP, GC, Corporate SecretaryS - Sale$21.44-1,76914,558-11%-$37,927
DM
2019-02-11
ENTAEnanta Pharmaceuticals IncCarter Bruce L ADirS - Sale+OE$90.01-7,7340-100%-$696,102
M
2019-02-11
RTRXRetrophin, Inc.Rote William E.SVP, R, DS - Sale$21.44-1,98516,007-11%-$42,558
M
2019-02-11
RTRXRetrophin, Inc.Clague LauraCFOS - Sale$21.44-2,03310,000-17%-$43,587
M
2019-02-11
RTRXRetrophin, Inc.Aselage SteveCEOS - Sale$21.44-2,130257,642-1%-$45,667
A
2018-04-30
BMYBristol Myers Squibb CoPaliwal Dinesh CDirP - Purchase$52.40+9,54012,935+281%+$499,896
2019-02-11
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, CROS - Sale$180.06-35,09553,262-40%-$6,319,216
2019-02-11
VRTXVertex Pharmaceuticals Inc / MaLeiden Jeffrey MCEO, PresS - Sale$180.24-111,431127,632-47%-$20,083,804
2019-02-11
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$180.21-33,07339,004-46%-$5,959,969
2019-02-11
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$180.22-32,95637,177-47%-$5,939,188
2019-02-11
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale$180.22-12,13640,627-23%-$2,187,190
2019-02-12
LCILannett Co IncLepore Patrick GDirP - Purchase$8.93+25,000117,895+27%+$223,250
D
2019-02-12
ZTSZoetis Inc.Peck Kristin CEVPS - Sale+OE$86.79-11,50029,652-28%-$998,085
2019-02-11
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, Interim CFOS - Sale$180.16-4,21520,740-17%-$759,367
2019-02-06
GTBPGt Biopharma, Inc.Cataldo TonyDirS - Sale$0.00-800,0004,029,600-17%-$800
AD
2018-12-12
CORTCorcept Therapeutics IncBelanoff Joseph KCEOS - Sale+OE$19.01-217,1152,164,195-9%-$4,126,509
DM
2019-02-08
ARWRArrowhead Pharmaceuticals, Inc.Given Bruce DCOOS - Sale+OE$16.04-242,834670,856-27%-$3,894,247
M
2019-02-08
XERSXeris Pharmaceuticals IncFlynn James EPossible Member of 10% Group, 10%S - Sale$15.09-7,2412,355,1360%-$109,251
M
2019-02-07
AMARAmarillo Biosciences IncChen Stephen TPres,COB,CEO,CFO, 10%P - Purchase$0.41+3,0006,616,3600%+$1,220
2019-02-12
GOSSGossamer Bio, Inc.Cox Russell J.DirP - Purchase$16.00+7,2007,200New+$115,200
D
2019-02-12
GOSSGossamer Bio, Inc.Christian WaageEVP, GCP - Purchase$16.00+1,550527,1740%+$24,800
D
2019-02-12
GOSSGossamer Bio, Inc.Giraudo BryanCFOP - Purchase$16.00+6,00023,879+34%+$96,000
2018-09-10
ETSTEarth Science Tech, Inc.Majorca Group, Ltd.10%S - Sale$0.75-480,00024,520,000-2%-$360,000
2019-02-08
ALPNAlpine Immune Sciences, Inc.Tiger Management L.L.C.10%S - Sale$5.85-25,000137,728-15%-$146,245
M
2019-02-07
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$13.53-13,0572,966,5730%-$176,676
D
2019-02-08
MRKMerck & Co., Inc.Brun Leslie ADirS - Sale+OE$77.22-3,0521,948-61%-$235,681
M
2019-02-06
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.03+38,00021,131,6230%+$985
2019-02-11
LCILannett Co IncCrew Timothy CCEOP - Purchase$8.48+4,00045,988+10%+$33,920
2019-02-07
GALTGalectin Therapeutics IncLewis JoelDirP - Purchase$4.48+1,00065,133+2%+$4,484
2019-02-08
GALTGalectin Therapeutics IncFreeman Kevin DDirP - Purchase$4.29+1,50039,543+4%+$6,428
D
2019-02-07
CELGCelgene Corp /de/Loughlin James JDirS - Sale+OE$87.29-23,46640,436-37%-$2,048,324
D
2019-02-07
CBAYCymabay Therapeutics, Inc.Goldfischer CarlDirS - Sale+OE$9.02-11,6750-100%-$105,328
D
2019-02-07
SRPTSarepta Therapeutics, Inc.Mahatme SandeshEVP, CFO, CBOS - Sale+OE$145.00-65,00020,661-76%-$9,425,000
D
2019-02-06
ARRYArray Biopharma IncLefkoff KyleDirS - Sale+OE$20.60-35,00057,720-38%-$721,074
D
2019-02-07
FGENFibrogen IncSchoeneck James ADirS - Sale+OE$57.17-2,00027,700-7%-$114,340
DM
2019-02-07
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$56.47-48,1802,808,289-2%-$2,720,677
D
2019-02-06
ARRYArray Biopharma IncRobbins Andrew RCOOS - Sale+OE$20.02-239,62659,994-80%-$4,798,511
DM
2019-02-06
ARRYArray Biopharma IncHaddock JasonCFOS - Sale+OE$21.80-96,71230,059-76%-$2,108,541
D
2019-02-07
ARRYArray Biopharma IncSaccomano Nicholas ACSOS - Sale+OE$21.58-187,264142,488-57%-$4,041,756
D
2019-02-07
ARRYArray Biopharma IncSquarer RonCEOS - Sale+OE$21.64-110,000238,709-32%-$2,380,015
D
2019-02-06
MGNXMacrogenics IncFust Matthew KDirS - Sale+OE$29.38-6,924500-93%-$203,427
2019-02-06
MGNXMacrogenics IncPeters Jeffrey StuartGCS - Sale$30.00-68202-25%-$2,040
D
2019-02-06
MGNXMacrogenics IncSpitznagel ThomasSVP, BPD, ManufacturingS - Sale+OE$30.00-1,7700-100%-$53,100
2019-02-06
PTGXProtagonist Therapeutics, IncPatel Dinesh V Ph DPres, CEOS - Sale$7.74-10,909357,264-3%-$84,410
M
2019-02-06
VERUVeru Inc.Steiner Mitchell ShusterPres, CEO, 10%S - Sale$1.50-10,4557,934,3120%-$15,724
2019-02-06
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerS - Sale$7.74-3,82137,007-9%-$29,562
2019-02-07
SPPISpectrum Pharmaceuticals IncMcGahan Keith MSVP, GCS - Sale$11.03-2,496104,887-2%-$27,541
2019-02-06
PTGXProtagonist Therapeutics, IncShames Richard S.Chief Medical OfficerS - Sale$7.74-2,77824,178-10%-$21,506
2019-02-08
SAGESage Therapeutics, Inc.Kanes StephenChief Medical OfficerS - Sale$150.00-22,948941-96%-$3,442,200
2019-02-06
NATRNatures Sunshine Products IncHughes Kristine FDirS - Sale$7.96-3,000650,7220%-$23,880
DM
2019-02-06
VCNXVaccinex, Inc.Royer Scott E.CFOP - Purchase$4.98+2,0003,999+100%+$9,968
2019-02-07
CYTKCytokinetics IncMalik Fady IbrahamEVP Research, DevelopmentS - Sale$7.28-1,50084,067-2%-$10,920
M
2019-02-06
MSLPMusclepharm CorpWynnefield Partners Small Cap Value LP I10%P - Purchase$0.40+100,0001,871,305+6%+$40,000
2019-02-04
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.03+4,00026,703,8970%+$103
2019-02-05
ARWRArrowhead Pharmaceuticals, Inc.Given Bruce DCOOS - Sale$14.48-22,500847,856-3%-$325,800
M
2019-02-05
XERSXeris Pharmaceuticals IncFlynn James EPossible Member of 10% Group, 10%S - Sale$15.02-14,8072,362,377-1%-$222,443
2019-02-05
AKAOAchaogen, Inc.Dorling JanetChief Commercial OfficerS - Sale$1.35-818285,8010%-$1,104
D
2019-02-05
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$98.63-4,000469,791-1%-$394,520
2019-02-05
PRTKParatek Pharmaceuticals, Inc.Woodrow AdamVP, Chief Commercial OfficerS - Sale$6.77-3,331144,694-2%-$22,551
2019-02-05
PRTKParatek Pharmaceuticals, Inc.Pagan Douglas W.CFOS - Sale$6.77-2,495134,057-2%-$16,891
2019-02-05
PRTKParatek Pharmaceuticals, Inc.Haskel William M.SVP, Sec., GCS - Sale$6.77-1,331112,220-1%-$9,011
D
2019-02-05
ARRYArray Biopharma IncOltmans Curtis GaleGCS - Sale+OE$20.00-40,00015,021-73%-$800,000
D
2019-02-05
DCPHDeciphera Pharmaceuticals, Inc.Bristol James ArthurDirS - Sale+OE$28.02-2,5950-100%-$72,704
2019-02-05
INSMInsmed IncAltomari AlfredDirS - Sale$25.00-5,50036,942-13%-$137,500
D
2019-02-05
AMPHAmphastar Pharmaceuticals, Inc.Zhou RongEVP, Production CenterS - Sale+OE$23.00-4,289156,698-3%-$98,647
D
2019-02-06
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, Interim CFOS - Sale+OE$193.00-1,28912,818-9%-$248,777
D
2019-02-05
DCPHDeciphera Pharmaceuticals, Inc.Taylor Michael DouglasPres, CEOS - Sale+OE$28.01-1,7000-100%-$47,611
D
2019-02-05
AMPHAmphastar Pharmaceuticals, Inc.Liawatidewi YakobSVP Corp Admin CenterS - Sale+OE$23.18-11,39742,252-21%-$264,167
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top